5 Result(s)

Article

Significance of men’s health in long-term survivors of allogeneic stem cell transplantation

Laila Schneidewind, Thomas Neumann, Nandette Peters… in Bone Marrow Transplantation (2022)

Article

Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

To investigate the efficacy and toxicities of CPX-351 outside a clinical trial, we analyzed 188 patients (median age 65 years, range 26–80) treated for therapy-related acute myeloid leukemia (t-AML, 29%) or AM...

Christina Rautenberg, Friedrich Stölzel, Christoph Röllig… in Blood Cancer Journal (2021)

Article

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT) remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases Working Group) of the D...

Andrew J. Ullmann, Martin Schmidt-Hieber, Hartmut Bertz… in Annals of Hematology (2016)

Article

Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

The Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) here presents its updated recommendations for the treatment of documented fungal infections. Invasive funga...

Sabine Mousset, Dieter Buchheidt, Werner Heinz, Markus Ruhnke… in Annals of Hematology (2014)

Article

Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies

The risk of infection after allogeneic stem cell transplantation is determined by the underlying disease, the intensity of previous treatments and complications that may have occurred during that time, but abo...

Hermann Einsele, Hartmut Bertz, Jörg Beyer, Michael G. Kiehl… in Annals of Hematology (2003)